Last week, FDA launched Drug Trials Snapshot, a pilot program intended to provide consumers with information about the sex, age, race and ethnicity of clinical participants for six drugs approved in May and June 2014.  This pilot is intended to solicit feedback on the content, format and usefulness of the information provided in advance of an expansion of the program to include all new molecular entities subject to an approved NDA beginning in 2015.

The Drug Trials Snapshot website was developed by FDA in response to the requirements in Section 907 of FDASIA that FDA: 1) report to Congress on certain information regarding clinical trial participation by demographic subgroups and subset analysis of the resulting data; and 2) address the extent to which clinical trial participation and the inclusion of safety and effectiveness data by demographic subgroups is included in applications submitted to FDA.  In response to these requirements, FDA developed an action plan that included the publication on FDA's website of demographic composition data and the resulting analysis by subgroup in pivotal clinical studies for FDA-approved medical products.

The initial pilot includes demographic subgroup information and related analyses for the following products:  Dalvance (dalbavancin hydrochloride, acute bacterial skin and skin structure infections); Entyvio (vedolizumab, Crohn's disease); Entyvio (vedolizumab, ulcerative colitis); Jublia (efinaconazole, onychomycosis); Sivextro (tedizolid; acute bacterial skin and skin structure infections); and Zontivity (vorapaxar, myocardial infarction and peripheral arterial disease).

Interested parties have until January 23, 2015 to submit comments electronically at or to submit written comments to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

Back to Health Law Advisor Blog

Search This Blog

Blog Editors


Related Services



Jump to Page


Sign up to receive an email notification when new Health Law Advisor posts are published:

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.